Company intelligence / Profile preview

Megelin

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Megelin (Shanghai) Biotechnology is a life science company specializing in the development and supply of high-quality research reagents and services. The company provides a comprehensive portfolio of products, including recombinant proteins, monoclonal and polyclonal antibodies, ELISA kits, and small molecule inhibitors, catering to the global academic and industrial research communities. Megelin focuses on supporting drug discovery and basic biological research through its expertise in protein engineering and immunology. Headquartered in Shanghai, the company serves as a key partner for laboratories and biotechnology firms seeking reliable tools for experimental validation and assay development.

Modalities: Small moleculeMonoclonal antibodyRecombinant proteinBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Megelin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Megelin.

Explore the full profile